Achilles Therapeutics plc American Depositary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ACHL Company Description
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
ACHL Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ACHL Smart Score
Score Breakdown
ACHL Company Description
Show More
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ACHL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ACHL's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on ACHL's company Twitter account
WallStreetBets
Number of mentions of ACHL in WallStreetBets Daily Discussion
ACHL News
Recent insights relating to ACHL
CNBC Recommendations
Recent picks made for ACHL stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ACHL
Corporate Flights
Flights by private jets registered to ACHL
Our Analysis